Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurofibromin 1 pseudogene 4 (NF1P4) is a non-coding pseudogene derived from the functional neurofibromin 1 (NF1) gene. NF1P4 and similar pseudogenes contain sequence resemblance to sections of the NF1 gene but do not encode functional protein products. Pseudogenes such as NF1P4 are distributed on several chromosomes, with some retaining significant homology to portions of the NF1 gene, but they lack important functional domains, such as the GAP-related domain crucial for tumor suppressor function in neurofibromin[2][5]. These pseudogenes are considered genetic relics arising from evolutionary duplication and transposition events and do not have known biological functions, disease associations, or relevance as drug targets. Key points distinguishing pseudogene from functional gene: - Pseudogenes like NF1P4 are non-functional genetic elements and are not considered therapeutic targets, receptors, or enzymes[2][5]. - The functional NF1 gene encodes neurofibromin, a tumor suppressor with a well-established role in regulating Ras/MAPK signaling, but NF1P4 has no such function[1][6]. - There are no disease associations, biological activities, or clinical applications (such as biomarker or drug target) for NF1P4. Summary of validity: NF1P4 is not a therapeutic target, but rather a pseudogene with no protein product or clinical relevance as a drug target, making it an "incorrect" entry for therapeutic target selection[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurofibromin 1 pseudogene 4 (NF1P4).